Rohit Loomba, MD, MHSc

Rohit Loomba, MD, MHSc

University of California at San Diego
Verified email at health.ucsd.edu
Cited by 80590
MASLD fatty liver NASH cirrhosis liver disease
Amalia Gastaldelli

Amalia Gastaldelli

Institute of Clinical Physiology, CNR
Verified email at cnr.it
Cited by 41186
MASLD diabetes metabolism metabolomics system biology
Nguan Soon Tan

Nguan Soon Tan

Nanyang Technological University Singapore
Verified email at ntu.edu.sg
Cited by 17263
Angiopoietin-like 4 Oxidative Stress MASLD Metastasis Wound healing
Yoshio Sumida

Yoshio Sumida

Healthcare management, Internarional University of Healthcare and Welfare
Verified email at koto.kpu-m.ac.jp
Cited by 12573
MASLD
Won Kim

Won Kim

Seoul National University, College of Medicine
Verified email at snu.ac.kr
Cited by 10887
MASLD ALD
Volker Lauschke

Volker Lauschke

Full Professor, Karolinska Institutet; Deputy Head, IKP
Verified email at ki.se
Cited by 8742
Personalized Medicine Pharmacogenomics Drug Development MASLD Translational pharmacology
Cheng Han Ng

Cheng Han Ng

Kurume University
Cited by 5383
Hepatology ALD MASLD HCC
Karn Wijarnpreecha, M.D., M.P.H.

Karn Wijarnpreecha, MD, MPH

Division of Gastroenterology and Hepatology, University of Arizona College of Medicine …
Verified email at email.arizona.edu
Cited by 5088
Gastroenterology Liver Transplantation Hepatology MASLD Epidemiology
A.G. (Onno) Holleboom, MD PhD, associate professor

AG (Onno) Holleboom, MD PhD, associate professor

Internist endocrinologist & vascular medicine, Amsterdam UMC, University of Amsterdam
Verified email at amsterdamumc.nl
Cited by 4899
MASLD metabolic liver disease diabetes mellitus cardiovascular disease lipoprotein biology
Marica Meroni

Marica Meroni

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano 20122 (ITALY)
Verified email at policlinico.mi.it
Cited by 4353
liver NAFLD NASH MASLD
1 - 10